CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down

EarningsNegative
AI Analysis

Summary

AbbVie reported Q2 earnings and sales that beat expectations but reduced its 2026 EPS guidance, resulting in a stock price decline.

Financial Highlights

Guidance

2026 EPS view cut

Importance:5/10
Sentiment:
-0.30
earningsguidance reductionstock decline
Related Companies

Read the original article

Published by yahoo_finance on July 31, 2026 5:11 PM

Read Original